These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15358978)

  • 1. A positron emission tomography study of the 5-HT1A receptor in schizophrenia and during clozapine treatment.
    Bantick RA; Montgomery AJ; Bench CJ; Choudhry T; Malek N; McKenna PJ; Quested DJ; Deakin JF; Grasby PM
    J Psychopharmacol; 2004 Sep; 18(3):346-54. PubMed ID: 15358978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered brain serotonin 5-HT1A receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [carbonyl11C]WAY-100635.
    Bailer UF; Frank GK; Henry SE; Price JC; Meltzer CC; Weissfeld L; Mathis CA; Drevets WC; Wagner A; Hoge J; Ziolko SK; McConaha CW; Kaye WH
    Arch Gen Psychiatry; 2005 Sep; 62(9):1032-41. PubMed ID: 16143735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occupancy of 5-HT1A receptors by clozapine in the primate brain: a PET study.
    Chou YH; Halldin C; Farde L
    Psychopharmacology (Berl); 2003 Mar; 166(3):234-40. PubMed ID: 12589516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occupancy of agonist drugs at the 5-HT1A receptor.
    Bantick RA; Rabiner EA; Hirani E; de Vries MH; Hume SP; Grasby PM
    Neuropsychopharmacology; 2004 May; 29(5):847-59. PubMed ID: 14985704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Verbal memory and 5-HT1A receptors in healthy volunteers--A PET study with [carbonyl-(11)C]WAY-100635.
    Penttilä J; Hirvonen J; Tuominen L; Lumme V; Ilonen T; Någren K; Hietala J
    Eur Neuropsychopharmacol; 2016 Mar; 26(3):570-7. PubMed ID: 26775837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635.
    Hirvonen J; Karlsson H; Kajander J; Lepola A; Markkula J; Rasi-Hakala H; Någren K; Salminen JK; Hietala J
    Int J Neuropsychopharmacol; 2008 Jun; 11(4):465-76. PubMed ID: 17971260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral D2 and 5-HT2 receptor occupancy in Schizophrenic patients treated with olanzapine or clozapine.
    Moresco RM; Cavallaro R; Messa C; Bravi D; Gobbo C; Galli L; Lucignani G; Colombo C; Rizzo G; Velonà I; Smeraldi E; Fazio F
    J Psychopharmacol; 2004 Sep; 18(3):355-65. PubMed ID: 15358979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortical and subcortical 5-HT2A receptor binding in neuroleptic-naive first-episode schizophrenic patients.
    Erritzoe D; Rasmussen H; Kristiansen KT; Frokjaer VG; Haugbol S; Pinborg L; Baaré W; Svarer C; Madsen J; Lublin H; Knudsen GM; Glenthoj BY
    Neuropsychopharmacology; 2008 Sep; 33(10):2435-41. PubMed ID: 18288096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of the serotonin 1A receptor availability in patients with schizophrenia during treatment with the antipsychotic medication ziprasidone.
    Frankle WG; Lombardo I; Kegeles LS; Slifstein M; Martin JH; Huang Y; Hwang DR; Reich E; Cangiano C; Gil R; Abi-Dargham A; Laruelle M
    J Psychopharmacol; 2011 Jun; 25(6):734-43. PubMed ID: 21109614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of aripiprazole, risperidone, and olanzapine on 5-HT1A receptors in patients with schizophrenia.
    Lerond J; Lothe A; Ryvlin P; Bouvard S; d'Amato T; Ciumas C; Daléry J; Poulet E; Saoud M
    J Clin Psychopharmacol; 2013 Feb; 33(1):84-9. PubMed ID: 23277246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KKHA-761, a potent D3 receptor antagonist with high 5-HT1A receptor affinity, exhibits antipsychotic properties in animal models of schizophrenia.
    Park WK; Jeong D; Cho H; Lee SJ; Cha MY; Pae AN; Choi KI; Koh HY; Kong JY
    Pharmacol Biochem Behav; 2005 Oct; 82(2):361-72. PubMed ID: 16216322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo occupancy of the 5-HT1A receptor by a novel pan 5-HT1(A/B/D) receptor antagonist, GSK588045, using positron emission tomography.
    Comley RA; van der Aart J; Gulyás B; Garnier M; Iavarone L; Halldin C; Rabiner EA
    Neuropharmacology; 2015 May; 92():44-8. PubMed ID: 25476970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No support for regional selectivity in clozapine-treated patients: a PET study with [(11)C]raclopride and [(11)C]FLB 457.
    Talvik M; Nordström AL; Nyberg S; Olsson H; Halldin C; Farde L
    Am J Psychiatry; 2001 Jun; 158(6):926-30. PubMed ID: 11384901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of aripiprazole on D(2), 5-HT(2), and 5-HT(1A) receptor occupancy in patients with schizophrenia: a triple tracer PET study.
    Mamo D; Graff A; Mizrahi R; Shammi CM; Romeyer F; Kapur S
    Am J Psychiatry; 2007 Sep; 164(9):1411-7. PubMed ID: 17728427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lateralization of the serotonin-1A receptor distribution in language areas revealed by PET.
    Fink M; Wadsak W; Savli M; Stein P; Moser U; Hahn A; Mien LK; Kletter K; Mitterhauser M; Kasper S; Lanzenberger R
    Neuroimage; 2009 Apr; 45(2):598-605. PubMed ID: 19103294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine, ziprasidone and aripiprazole but not haloperidol protect against kainic acid-induced lesion of the striatum in mice, in vivo: role of 5-HT1A receptor activation.
    Cosi C; Waget A; Rollet K; Tesori V; Newman-Tancredi A
    Brain Res; 2005 May; 1043(1-2):32-41. PubMed ID: 15862515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS.
    Turner MR; Rabiner EA; Hammers A; Al-Chalabi A; Grasby PM; Shaw CE; Brooks DJ; Leigh PN
    Brain; 2005 Apr; 128(Pt 4):896-905. PubMed ID: 15689356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain serotonin 5-HT(1A) receptor binding in schizophrenia measured by positron emission tomography and [11C]WAY-100635.
    Tauscher J; Kapur S; Verhoeff NP; Hussey DF; Daskalakis ZJ; Tauscher-Wisniewski S; Wilson AA; Houle S; Kasper S; Zipursky RB
    Arch Gen Psychiatry; 2002 Jun; 59(6):514-20. PubMed ID: 12044193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin transporter genotype is associated with cognitive performance but not regional 5-HT1A receptor binding in humans.
    Borg J; Henningsson S; Saijo T; Inoue M; Bah J; Westberg L; Lundberg J; Jovanovic H; Andrée B; Nordstrom AL; Halldin C; Eriksson E; Farde L
    Int J Neuropsychopharmacol; 2009 Jul; 12(6):783-92. PubMed ID: 19126263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serotonin 1A receptor availability in patients with schizophrenia and schizo-affective disorder: a positron emission tomography imaging study with [11C]WAY 100635.
    Frankle WG; Lombardo I; Kegeles LS; Slifstein M; Martin JH; Huang Y; Hwang DR; Reich E; Cangiano C; Gil R; Laruelle M; Abi-Dargham A
    Psychopharmacology (Berl); 2006 Dec; 189(2):155-64. PubMed ID: 16953380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.